Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.